CRYOVALVE SG PULMONARY HUMAN HEART VALVE (AND CONDUIT)
A Cardiovascular Implant - Heart Valve Related Image
(Not Necessarily related to the device)Description:
CRYOVALVE SG PULMONARY HUMAN HEART VALVE (AND CONDUIT) by CRYOLIFE INC.
The CRYOVALVE SG PULMONARY HUMAN HEART VALVE is an innovative medical device designed to replace dysfunctional or disease-ridden pulmonary valves in patients. This is an allograft, also known as a homograft, which means that the valve is acquired from human donor tissue. The device is processed using CRYOLIFE INC.'s proprietary SynerGraft technology, a remarkable solution that decellularizes the native heart valves and vessels, making it more compatible for patient implantation.
The primary role of the device is to facilitate and regulate the flow of blood from the right ventricle of the heart to the pulmonary arteries. It can be used as either a standalone valve or in conjunction with a conduit that replaces both valve and the artery if required.
One of the significant benefits of the CRYOVALVE SG PULMONARY HUMAN HEART VALVE is that the SynerGraft technology significantly reduces the potentiality for a patient's immune response. This facilitates the body's acceptance of the new valve, paving the way for optimal recovery.
The CRYOVALVE SG PULMONARY HUMAN HEART VALVE functions by mimicking the mechanism of sincere, naturally occurring human valves. Once it's surgically implanted in place of the original, diseased valve, the CRYOVALVE opens and shuts in synchronization with the heart's rhythm, ensuring smooth, efficient blood flow from the heart, towards the lungs for oxygenation.
With the CRYOVALVE SG PULMONARY HUMAN HEART VALVE, patients have access to a device that offers a high level of biocompatibility, enabling a normal, healthy cardiac function. This efficient solution brings optimal outcomes for those in need of heart valve repair or replacement.
Primary Use:
The CryoValve SG Pulmonary Human Heart Valve is primarily utilized in cardiovascular surgeries for the replacement of damaged or malfunctioning pulmonary valves. This biological device, derived from human tissue, is especially useful in procedures where the natural pulmonary valve needs to be replaced due to conditions such as congenital heart defects, disease, or deterioration. It serves the key function of facilitating proper blood flow from the heart to the lungs. When integrated into the patient's heart, the CryoValve SG replaces the faulty
How It Works:
The CryoValve SG Pulmonary Human Heart Valve and Conduit is a unique implement within the cardiovascular surgical devices category. This device is a preserved homograft valve, meaning it is obtained from a human donor, then preserved and sterilized for surgical implantation into a recipient. The CryoValve SG is specifically a pulmonary valve, used to replace a patient's malfunctioning or diseased pulmonary valve. This device is intended to help manage and mitigate defects and severe cardiovascular disorders through surgical intervention. As to how this device functions: the pulmonary valve itself plays a crucial role in the cardiac cycle. It allows blood to flow from the right ventricle (one of the heart's four chambers) into the pulmonary artery, which carries deoxygenated blood into the lungs for oxygenation. Once the blood is in the pulmonary artery, the pulmonary valve closes to prevent any blood from flowing back into the right ventricle. The CryoValve SG Pulmonary Human Heart Valve works in precisely the same manner. During a surgical procedure, the diseased or defective pulmonary valve is removed from the patient's heart, and the CryoValve SG is sewn into its place. Once the homograft is implanted, it will begin to function as a normal pulmonary valve would. The term "CryoValve" denotes the specific cryopreservation process this valve goes through after being harvested from the donor. Cryopreservation is a controlled method that involves freezing and storing the valve at very cold temperatures to prevent any cellular degradation. The 'SG' stands for SynerGraft, a technology used by CryoLife, which aims to decellularize the human heart valves, effectively reducing the immunogenicity (the ability to provoke an immune response in the body) of the implant. The CryoValve SG Pulmonary Human Heart Valve and the conduit have been designed and processed in a way that ensures a combination of tissue strength, longevity, and reduced potential for rejection. This makes them ideal for heart valve replacement surgeries, such as pulmonary valve replacement, especially in pediatric cases where growth accommodation is important. I hope this explanation provides comprehensive insight into how the CryoValve SG Pulmonary Human Heart Valve and Conduit function within the realm of cardiovascular medical devices. This work is a testament to ongoing innovations in the medical field, combining advanced technology with biology to enhance and lengthen lives.Manufacturer:
CRYOLIFE INC.
Status: In Stock
Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.